INS and early-onset autosomal dominant Alzheimer disease: Interestingly, Intranasal insulin, metformin, incretins, and thiazolidinediones are a few examples of anti-diabetic drugs that have been demonstrated in human studies to improve cognition and memory in individuals with mild cognitive impairment and Alzheimer’s disease (Michailidis et al. 2022).